Bapineuzumab (AAB-001) is a humanised monoclonal antibody targeting amyloid-beta (Abeta), capable of binding to the N-terminal region of both soluble and oligomeric forms of amyloid beta, and is used for research into Alzheimers disease (AD).
Purity:
95.00%
CAS Number:
[648895-38-9]
Target:
Beta Amyloid
* VAT and and shipping costs not included. Errors and price changes excepted
